Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tenax Therapeutics (TENX)
NASDAQ:TENX
Holding TENX?
Track your performance easily
TENX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.77 - $61.20
Previous Close$5
Volume53.06K
Average Volume (3M)55.67K
Market Cap
$17.04M
Enterprise Value$17.31M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$278.80K
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.37
Shares Outstanding3,408,906
10 Day Avg. Volume38,922
30 Day Avg. Volume55,674
Standard Deviation0.32
R-Squared0.12
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)1.89
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-13.42
Forecast
1Y Price Target
$20.67Price Target Upside321.84% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Tenax Therapeutics News
PremiumCompany Announcements
Tenax Therapeutics Expands Stock Incentive Plan
Ownership Overview
0.21% Insiders
0.39% Mutual Funds
― Other Institutional Investors
99.26% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TENX FAQ
What was Tenax Therapeutics’s price range in the past 12 months?
Tenax Therapeutics lowest stock price was $2.77 and its highest was $61.20 in the past 12 months.
What is Tenax Therapeutics’s market cap?
Currently, no data Available
When is Tenax Therapeutics’s upcoming earnings report date?
Tenax Therapeutics’s upcoming earnings report date is Mar 27, 2025 which is in 125 days.
How were Tenax Therapeutics’s earnings last quarter?
Tenax Therapeutics released its earnings results on Aug 13, 2024. The company reported -$1.83 earnings per share for the quarter, beating the consensus estimate of -$1.985 by $0.155.
Is Tenax Therapeutics overvalued?
According to Wall Street analysts Tenax Therapeutics’s price is currently Undervalued.
Does Tenax Therapeutics pay dividends?
Tenax Therapeutics does not currently pay dividends.
What is Tenax Therapeutics’s EPS estimate?
Tenax Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tenax Therapeutics have?
Tenax Therapeutics has 3,408,906 shares outstanding.
What happened to Tenax Therapeutics’s price movement after its last earnings report?
Tenax Therapeutics reported an EPS of -$1.83 in its last earnings report, beating expectations of -$1.985. Following the earnings report the stock price went down -1.985%.
Which hedge fund is a major shareholder of Tenax Therapeutics?
Currently, no hedge funds are holding shares in TENX
---
Tenax Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.67 (321.84% Upside)
$20.67 (321.84% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 20.7%
Last 30 Days ▲ 20.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-59.95%
12-Months-Change
Fundamentals
Return on Equity
-113.79%
Trailing 12-Months
Asset Growth
-24.41%
Trailing 12-Months
Company Description
Tenax Therapeutics
Tenax Therapeutics, Inc. is a pharmaceutical company, which engages in the identification, development, and commercialization of novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.
---
TENX Stock 12 Month Forecast
Average Price Target
$20.67
▲(321.84% Upside)
Technical Analysis
Best Analysts Covering TENX
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
-32.55%
reiterated a buy rating 3 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -32.55% per trade.
---